US exceeds 1,900 measles cases as outbreaks expand

The CDC reported 1,912 confirmed U.S. measles cases in 2025, up 84 from last week, with 88% outbreak-associated across 47 outbreaks and three deaths; ongoing transmission from a West Texas outbreak that sickened roughly 800 people threatens the country’s measles elimination status in January 2026 as holiday travel and indoor gatherings increase. Large clusters in the Utah‑Arizona corridor (254 cases, second-largest this year), Arizona (176 cases concentrated in Mohave County/Colorado City) and South Carolina (114 cases, with 281 students quarantined) have been driven by school and church exposures in low‑vaccination communities; 92% of cases are unvaccinated or have unknown status, 11% required hospitalization and 21% of cases in children under five have needed hospital care.

Analysis

The CDC reported 1,912 confirmed U.S. measles cases in 2025, an increase of 84 from last week, with 88% of cases outbreak-associated across 47 outbreaks; ongoing transmission from a West Texas outbreak that sickened roughly 800 people places U.S. measles elimination status at risk in January 2026. These figures mark a significant escalation from 2024, when 16 outbreaks were reported and 69% of cases were outbreak-associated, signaling more sustained community transmission this year.

Large localized clusters are driving the surge: the Utah–Arizona corridor accounts for a 254-case outbreak (second-largest this year), Arizona has 176 cases concentrated in Mohave County/Colorado City, and South Carolina reports 114 cases with 281 students quarantined. The outbreaks are tied to exposures at schools and churches in communities with low vaccination uptake; 92% of confirmed cases are in people unvaccinated or with unknown vaccination status.

Clinical severity and system stress are visible: three confirmed deaths, 11% of patients hospitalized overall and 21% of cases in children under five requiring hospital care, and public-health officials warn holiday gatherings and travel may accelerate spread. Market signals show moderately negative sentiment with a low market impact score (0.12), suggesting limited broad-market disruption but potential sector-specific demand for vaccines, diagnostics, public-health services and localized economic effects.

Key Decisions for Investors

• Do not overhaul broad equity allocations given the low market impact score (0.12); favor tactical, sector-specific exposure rather than broad market bets
• Consider increasing or initiating selective exposure to vaccine manufacturers, diagnostics and public-health service providers likely to benefit from heightened vaccination and outbreak-response activity
• Monitor CDC weekly case counts, outbreak tallies and the January 2026 elimination-status decision as triggers for policy changes or funding that could affect healthcare-related equities
• Assess regional risk for holdings with concentrated exposure to Arizona (Mohave County), Utah and South Carolina where quarantines and school closures may hit local revenues and service providers, and consider short-term hedges for insurers and hospital operators if hospitalization trends worsen